National Advisory Council Agenda

142nd Meeting of the National Advisory Council on Drug Abuse

Virtual Meeting – September 13, 2022

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2). 

Time Presentation
11:00 a.m. Call to Order
Nora Volkow, M.D.
Director, NIDA


Review of Policy and Procedures
Susan Weiss, Ph.D.
Executive Secretary
National Advisory Council on Drug Abuse
Director, Division of Extramural Research, NIDA
11:15 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Office of Translational Initiatives and Program Innovationa (OTIPI)
Elena Koustova, Ph.D., M.B.A., Director

Division of Therapeutics and Medical Consequences (DTMC)
Iván Montoya, M.D., M.P.H., Acting Director

Division of Neuroscience and Behavior (DNB)
Rita Valentino, Ph.D., Director

Office of Research Training, Diversity, and Disparities (ORTDD)
Albert Avilla, Ph.D., Deputy Director

12:15 p.m. Break

Videocast:

Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Gillian Acca, within ten days of the meeting.  Any written statements by members of the public will receive careful consideration.

Join the Videocast

Open Session

Time Presentation
12:45 p.m. Welcome and Opening Remarks
Nora Volkow, M.D., Director, NIDA
1:00 p.m. ONDCP Presentation
Rahul Gupta, M.D., M.P.H., M.B.A., FACP, Director, Office of National Drug Control Policy
1:50 p.m. Director's Report
Nora Volkow, M.D., Director, NIDA
2:40 p.m. Discussion
Council Members
3:05 p.m. Break
3:20 p.m. Updates from the Office of Science Policy and Communications
Jennifer A. Hobin, Ph.D., Director, Office of Science Policy and Communications
Emily Einstein, Ph.D., Chief, Science Policy Branch
4:10 p.m. Concept Clearances​
  • Division of Epidemiology, Services, and Prevention Research (DESPR)
    • Patient Engagement Resource Centers – Lori Ducharme, Ph.D., Health Scientist Administrator
    • Leveraging Inpatient Medical or Surgical Hospitalizations to Improve Outcomes for People Who Use Drugs – Marcy Fitz-Randolph, D.O., MPH, Medical Officer
    • Rapid Translation of Epidemiological Findings into Interventions to Prevent Substance Use and Addiction – Alexa Romberg, Ph.D., Social Behavioral Scientist Administrator
    • Rural Community-Centered Prevention and Harm Reduction Research: Responding to the Fourth Wave Opioid/Psychostimulant Epidemic and its HIV/HCV Consequences in the U.S. – Aria Crump, Sc.D., Deputy Branch Chief, Prevention Research Branch
  • Office of Translational Initiatives and Program Innovations (OTIPI)
    • Using Cost‐Effective Technology to Develop Accessible and Affordable Products to Reduce (or even eliminate) Disparities in Substance Use Disorder (SUD) Diagnosis and Treatment – Yordan Kostov, Ph.D., Health Scientist Administrator
  • Division of Therapeutics and Medical Consequences (DTMC)
    • Marijuana Farm and Analytics to Produce Consistent, High Quality Material to Facilitate Cannabis Research – Jane Acri, Ph.D., Acting Deputy Director
  • Division of Neuroscience and Behavior (DNB)
    • Exploratory Clinical Neuroscience Research on Substance Use Disorders – Vani Pariyadath, Ph.D.,Chief, Behavioral and Cognitive Neuroscience Branch
    • Responsible Analyses of Complex, Large‐Scale Data – Vani Pariyadath, Ph.D.,Chief, Behavioral and Cognitive Neuroscience Branch
    • Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TransSINDA) – Holly Moore, Ph.D., Health Scientist Administrator
    • Mechanistic Research on Neuromodulation for SUD Treatment – John Fedota, Ph.D., Health Scientist Administrator
    • Advancing Psychedelics Research for Treating Addiction – Kiran Vemuri, Ph.D., Health Scientist Administrator
    • Remote Assessment 1: Identifying and Addressing Barriers to Participant Engagement – Janani Prabhakar, Ph.D., Health Scientist Administrator
    • Remote Assessment 2: Validation and Expansion of Remote Assessments of SUD-Relevant Behaviors – John Fedota, Ph.D., Health Scientist Administrator
  • Office of Research Training, Diversity, and Disparities (ORTDD)
    • NIDA International Program – Lindsey Friend, Ph.D., Health Scientist Administrator
4:45 p.m. Public Comments
5:00 p.m. Adjourn